Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe

M. Zemanova, M. Jakopovic, K. Stanic, M. Łazar-Poniatowska, M. Vrankar, P. Rusu, T. Ciuleanu, D. Radosavljevic, K. Bogos, S. Nawrocki

. 2020 ; 54 (4) : 447-454. [pub] 20201011

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21026488

Background The aim of this project was to collect real-world evidence and describe treatment patterns for stage III non-small cell lung cancer in Central and Eastern Europe. Based on real-world evidence, an expert opinion was developed, and the unmet needs and quality indicators were identified. Patients and methods A systematic literature search and a multidisciplinary expert panel of 10 physicians from 7 countries used a modified Delphi process to identify quality indicators and unmet needs in patients with stage III non-small cell lung cancer. The profound questionnaire was used to characterize treatment patterns used for stage III non-small cell lung cancer, and a systematic review identified patterns in Central and Eastern Europe. The first questionnaire was completed by a group of medical oncologists, radiation oncologists and pneumologists. The panel of experts attended an in-person meeting to review the results of the questionnaire and to process a second round Delphi. An additional survey was then compiled and completed by the panel. Results A complete consensus was reached by the panel of experts on a set of evidence-based clinical recommendations. The experience-based questionnaire generated a highly variable map of treatment patterns within the region. A list of unmet needs and barriers to quality care were developed with near-unanimous consent of the panel of experts. Conclusions The current landscape of diagnostic and therapeutic approaches in Central and Eastern European countries is highly variable. We identified several significant barriers, mainly related to the availability of diagnostic and imaging methods and low rates of chemoradiotherapy with curative intention as initial treatment for unresectable stage III NSCLC.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21026488
003      
CZ-PrNML
005      
20211026132851.0
007      
ta
008      
211013s2020 pl f 000 0|eng||
009      
AR
024    7_
$a 10.2478/raon-2020-0058 $2 doi
035    __
$a (PubMed)33048837
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Zemanova, Milada $u 1st Faculty of Medicine of Charles University, Prague, Czech Republic
245    10
$a Treatment patterns and real-world evidence for stage III non-small cell lung cancer in Central and Eastern Europe / $c M. Zemanova, M. Jakopovic, K. Stanic, M. Łazar-Poniatowska, M. Vrankar, P. Rusu, T. Ciuleanu, D. Radosavljevic, K. Bogos, S. Nawrocki
520    9_
$a Background The aim of this project was to collect real-world evidence and describe treatment patterns for stage III non-small cell lung cancer in Central and Eastern Europe. Based on real-world evidence, an expert opinion was developed, and the unmet needs and quality indicators were identified. Patients and methods A systematic literature search and a multidisciplinary expert panel of 10 physicians from 7 countries used a modified Delphi process to identify quality indicators and unmet needs in patients with stage III non-small cell lung cancer. The profound questionnaire was used to characterize treatment patterns used for stage III non-small cell lung cancer, and a systematic review identified patterns in Central and Eastern Europe. The first questionnaire was completed by a group of medical oncologists, radiation oncologists and pneumologists. The panel of experts attended an in-person meeting to review the results of the questionnaire and to process a second round Delphi. An additional survey was then compiled and completed by the panel. Results A complete consensus was reached by the panel of experts on a set of evidence-based clinical recommendations. The experience-based questionnaire generated a highly variable map of treatment patterns within the region. A list of unmet needs and barriers to quality care were developed with near-unanimous consent of the panel of experts. Conclusions The current landscape of diagnostic and therapeutic approaches in Central and Eastern European countries is highly variable. We identified several significant barriers, mainly related to the availability of diagnostic and imaging methods and low rates of chemoradiotherapy with curative intention as initial treatment for unresectable stage III NSCLC.
650    _2
$a dospělí $7 D000328
650    _2
$a nemalobuněčný karcinom plic $x epidemiologie $x patologie $x terapie $7 D002289
650    _2
$a konsensus $7 D032921
650    _2
$a delfská metoda $7 D003697
650    _2
$a medicína založená na důkazech $7 D019317
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a nádory plic $x epidemiologie $x patologie $x terapie $7 D008175
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a staging nádorů $7 D009367
650    _2
$a lékařská praxe - způsoby provádění $x statistika a číselné údaje $7 D010818
650    _2
$a průzkumy a dotazníky $7 D011795
651    _2
$a Evropa $x epidemiologie $7 D005060
651    _2
$a východní Evropa $x epidemiologie $7 D005061
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jakopovic, Marko $u Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, Zagreb, Croatia
700    1_
$a Stanic, Karmen $u Institute of Oncology Ljubljana, Ljubljana, Slovenia $u Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
700    1_
$a Łazar-Poniatowska, Małgorzata $u Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland
700    1_
$a Vrankar, Martina $u Institute of Oncology Ljubljana, Ljubljana, Slovenia $u Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
700    1_
$a Rusu, Petronela $u Institute of Oncology "Prof. Dr. Ion Chiricuta", Cluj-Napoca, Romania
700    1_
$a Ciuleanu, Tudor $u Institute of Oncology "Prof. Dr. Ion Chiricuta", Cluj-Napoca, Romania
700    1_
$a Radosavljevic, Davorin $u Institute for Oncology and Radiology of Serbia, Belgrade, Serbia
700    1_
$a Bogos, Krisztina $u National Koranyi Institute of TB and Pulmonology, Budapest, Hungary
700    1_
$a Nawrocki, Sergiusz $u Department of Oncology, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland
773    0_
$w MED00004048 $t Radiology and oncology $x 1581-3207 $g Roč. 54, č. 4 (2020), s. 447-454
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33048837 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026132857 $b ABA008
999    __
$a ok $b bmc $g 1715265 $s 1146995
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 54 $c 4 $d 447-454 $e 20201011 $i 1581-3207 $m Radiology and oncology $n Radiol. oncol. (Tik. izd.) $x MED00004048
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace